| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Apr―17 |
Mapping the evidence: a scoping review of the impact of COVID-19 on non-communicable disease care in Sub-Saharan Africa |
Elsie C. Kruger, Aaqilah Fataar, Andre P. Kengne, Rajiv T. Erasmus, Annalise E. Zemlin |
| 2 |
[GO] |
2025―Dez―09 |
Omics-based computational approaches for biomarker identification, prediction, and treatment of Long COVID |
Sindy Pinero, Xiaomei Li, Junpeng Zhang, Marnie Winter, Sang Hong Lee, Thin Nguyen, Lin Liu, Jiuyong Li, Thuc Duy Le |
| 3 |
[GO] |
2023―Okt―06 |
Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics |
Chun Yiu Jordan Fung, Mackenzie Scott, Jordan Lerner-Ellis, Jennifer Taher |
| 4 |
[GO] |
2023―Jul―13 |
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19 |
James V. Harte, Caroline Coleman-Vaughan, Maeve P. Crowley, Vitaliy Mykytiv |
| 5 |
[GO] |
2023―Feb―24 |
Current status in cellular-based therapies for prevention and treatment of COVID-19 |
Dima Hattab, Mumen F. A. Amer, Amirah Mohd Gazzali, Lay Hong Chuah, Athirah Bakhtiar |
| 6 |
[GO] |
2022―Aug―05 |
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology |
Dorsa Sohaei, Morley Hollenberg, Sok-Ja Janket, Eleftherios P. Diamandis, Gennady Poda, Ioannis Prassas |
| 7 |
[GO] |
2022―Mrz―15 |
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future |
Fausto Baldanti, Nirmal K. Ganguly, Guiqiang Wang, Martin Möckel, Luke A. O’Neill, Harald Renz, Carlos Eduardo dos Santos Ferreira, Kazuhiro Tateda, Barbara Van Der Pol |
| 8 |
[GO] |
2021―Okt―02 |
The COVID-19 pandemic: viral variants and vaccine efficacy |
Marco Ciotti, Massimo Ciccozzi, Massimo Pieri, Sergio Bernardini |
| 9 |
[GO] |
2021―Sep―14 |
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19 |
Selina Wolfisberg, Claudia Gregoriano, Philipp Schuetz |
| 10 |
[GO] |
2021―Jul―08 |
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies |
Francesca Sanguedolce, Magda Zanelli, Elisabetta Froio, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Giovanni Stallone, Stefano Netti, Elena Ranieri, Ugo Falagario, Giuseppe Carrieri, Luigi Cormio |
| 11 |
[GO] |
2021―Feb―19 |
Molecular diagnostic assays for COVID-19: an overview |
Parham Habibzadeh, Mohammad Mofatteh, Mohammad Silawi, Saeid Ghavami, Mohammad Ali Faghihi |
| 12 |
[GO] |
2020―Dez―30 |
Progress in understanding COVID-19: insights from the omics approach |
Baoxu Lin, Jianhua Liu, Yong Liu, Xiaosong Qin |
| 13 |
[GO] |
2020―Dez―21 |
COVID-19: from3 an acute to chronic disease? Potential long-term health consequences |
Victoria Higgins, Dorsa Sohaei, Eleftherios P. Diamandis, Ioannis Prassas |
| 14 |
[GO] |
2020―Nov―27 |
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19 |
Majid Vatankhah, Amir Azizi, Anahita Sanajouyan Langeroudi, Sajad Ataei Azimi, Imaneh Khorsand, Mohammad Amin Kerachian, Jamshid Motaei |
| 15 |
[GO] |
2020―Jul―09 |
The COVID-19 pandemic |
Marco Ciotti, Massimo Ciccozzi, Alessandro Terrinoni, Wen-Can Jiang, Cheng-Bin Wang, Sergio Bernardini |
| 16 |
[GO] |
2020―Jun―22 |
A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients |
T. A. (Tania) Khartabil, H. (Henk) Russcher, AJAM (Andre) van der Ven, Y. B. (Yolanda) de Rijke |
| 17 |
[GO] |
2020―Jun―17 |
The laboratory’s role in combating COVID-19 |
Bingliang Fang, Qing H. Meng |
| 18 |
[GO] |
2020―Jun―06 |
Biomarkers associated with COVID-19 disease progression |
Giovanni Ponti, Monia Maccaferri, Cristel Ruini, Aldo Tomasi, Tomris Ozben |
